About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brightspire Capital Inc (NY: BRSP )

6.080 -0.130 (-2.09%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Brightspire Capital Inc

< Previous 1 2 Next >
BRSP Stock Earnings: BrightSpire Capital Meets EPS, Beats Revenue for Q2 2024
BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
BRSP Stock Earnings: BrightSpire Capital Beats EPS, Beats Revenue for Q1 2024
BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead'
Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why. 
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
Earnings Preview For BrightSpire Capital
Via Benzinga
Earnings Outlook For BrightSpire Capital
Via Benzinga
Looking Into BrightSpire Capital's Return On Capital Employed
Via Benzinga
BrightSpire Capital: Q1 Earnings Insights
Via Benzinga
Looking Into BrightSpire Capital's Return On Capital Employed
Via Benzinga
US Mortgage Applications Surge As Rates Dip: Is The Industry Moving Out Of The Woods? Plus: Stocks, ETFs To Watch
The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications. 
Via Benzinga
Topics ETFs
These 3 REITs Just Jumped Higher On Earnings Beats
Via Benzinga
The Best-Performing Mortgage REITs In 2023
Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Via Benzinga
Recap: BrightSpire Capital Q1 Earnings
BrightSpire Capital (NYSE:BRSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
A Look Into Real Estate Sector Value Stocks
Via Benzinga
These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worth
The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
BrightSpire Capital: Q3 Earnings Insights
BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital... 
Via Benzinga
BrightSpire Capital: Q2 Earnings Insights
  BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
BrightSpire Capital's Return On Capital Employed Insights
According to Benzinga Pro, during Q4, BrightSpire Capital (NYSE:BRSP) earned $83.26 million, a 216.15% increase from the preceding quarter. BrightSpire Capital also posted a total... 
Via Benzinga
Recap: BrightSpire Capital Q4 Earnings
BrightSpire Capital (NYSE:BRSP) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.